RELATING TO MENTAL HEALTH.
Summary
Establishes a two-year Mental Health Emerging Therapies Pilot Program within the Office of Wellness and Resilience. Appropriates funds. Effective 7/1/3000. (HD1)
Bill status
passed both
4 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Apr 2025
Senate Passage
Feb 2025
House Passage
Apr 2025
Governor
Introduced Jan 17, 2025
Last action Apr 25, 2025
Maddy AI version diff · 2 comparisons
What changed between versions
SB1042_HD1
→
SB1042_SD1
·
6 edits
MODERATE
The bill was substantially rewritten to shift from an Office of Wellness and Resilience pilot program to a Department of Health special fund. The new version establishes a permanent special fund in the state treasury rather than a temporary two-year pilot, expands the scope of allowed activities to include compassionate use programs, and changes the effective date from July 1, 3000 to December 31, 2050. The Department of Health now administers the fund instead of the Office of Wellness and Resilience.
Scope change
The bill's scope changed from a limited two-year pilot program to a permanent special fund with expanded activities including compassionate use programs and public-private partnerships for FDA breakthrough therapies.
FISCAL
Changed from a temporary two-year pilot program to a permanent mental health emerging therapies special fund in the state treasury.
REQUIREMENT
Administrative authority shifted from the Office of Wellness and Resilience to the Department of Health.
Reporting requirements changed to require annual reports to the legislature beginning with the 2026 regular session.
SCOPE
Added compassionate use programs for terminal or life-threatening conditions to the list of allowable activities.
TIMELINE
Effective date changed from July 1, 3000 to December 31, 2050.
DEFINITION
Added specific definitions for 'compassionate use' and 'United States Food and Drug Administration breakthrough therapies'.
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
32
Key actions
10
Committee
12
Amendments
1
Apr 25, 2025
Upper · Passed
Conference committee meeting to reconvene on 04-25-25 5:20 PM; Conference Room 329.
upper
Apr 24, 2025
Upper · Passed
Conference committee meeting scheduled for 04-25-25 3:15PM; Conference Room 329.
upper
Apr 10, 2025
Amended
Senate disagrees with House amendments.
upper
Apr 10, 2025
Introduced
Received from House (Hse. Com. No. 668).
upper
Apr 8, 2025
Lower · Passed
Passed Third Reading with none voting aye with reservations; Representative(s) Kila, Kitagawa, Lamosao, Matayoshi, Pierick voting no (5) and Representative(s) Cochran, Marten excused (2). Transmitted to Senate.
lower
Apr 2, 2025
Lower · Passed
The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 15 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Lee, M., Miyake, Morikawa, Templo, Alcos, Reyes Oda; Ayes with reservations: none; Noes: none; and Excused: none.
lower
Mar 18, 2025
Committee
Reported from HLT (Stand. Com. Rep. No. 1312) as amended in HD 1, recommending passage on Second Reading and referral to FIN.
lower
Mar 14, 2025
Lower · Passed
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.
lower
Mar 4, 2025
Committee
Referred to HLT, FIN, referral sheet 18
lower
Feb 28, 2025
Introduced
Received from Senate (Sen. Com. No. 50) in amended form (SD 1).
lower
Feb 28, 2025
Upper · Passed
Report Adopted; Passed Third Reading. Ayes, 22; Aye(s) with reservations: Senator(s) McKelvey. Noes, 1 (Senator(s) Awa). Excused, 2 (Senator(s) Fukunaga, Kidani). Transmitted to House.
upper
Feb 19, 2025
Upper · Passed
The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED. The votes in WAM were as follows: 13 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
upper
Feb 14, 2025
Upper · Passed
The committee(s) on WAM will hold a public decision making on 02-19-25 10:02AM; Conference Room 211 & Videoconference.
upper
Feb 14, 2025
Committee
Reported from HHS (Stand. Com. Rep. No. 625) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
upper
Feb 12, 2025
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
upper
Feb 7, 2025
Upper · Passed
The committee(s) on HHS has scheduled a public hearing on 02-12-25 1:00PM; Conference Room 225 & Videoconference.
upper
Jan 23, 2025
Committee
Referred to HHS, WAM.
upper
Jan 17, 2025
Introduced
Introduced.
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Stanley Chang
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 1042
Scope: HI
Hi! I can help you understand SB 1042. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline